Articles published by Benzinga
DEA's Case For Scheduling Psychedelics Challenged In Landmark Hearing
November 20, 2024
Via Benzinga
Chevron Options Trading: A Deep Dive into Market Sentiment
November 20, 2024
Via Benzinga
Tickers
CVX
Global-E Soars: Q3 Sales Surge 32%, FY24 Outlook Raised Amid GMV Boom
November 20, 2024
Via Benzinga
Snowflake Q3 Earnings: Will Bullish Charts, Analyst Optimism Offset The 32% YTD Decline?
November 20, 2024
Via Benzinga
Tickers
SNOW
Will Nvidia Deliver A 'Blowout Beat' In Q3? Poll Says Maybe Not, But Over Half See Stock Clearing $150
November 20, 2024
Via Benzinga
Tickers
NVDA
A Glimpse of Matthews International's Earnings Potential
November 20, 2024
Via Benzinga
Tickers
MATW
Spotlight on ServiceNow: Analyzing the Surge in Options Activity
November 20, 2024
Via Benzinga
Tickers
NOW
Breaking Down Halozyme Therapeutics: 10 Analysts Share Their Views
November 20, 2024
Via Benzinga
Tickers
HALO
What's Going On With Marvell Technology (MRVL) Shares?
November 20, 2024
Via Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
What's Going On With Faraday Future Intelligent Electric Stock?
November 20, 2024
Via Benzinga
Tickers
FFIE
What's Going On With Micron Stock Ahead Of Nvidia Earnings?
November 20, 2024
Via Benzinga
Salesforce Tool Aims To Simplify AI Agent Testing, Deployment
November 20, 2024
Via Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free